NPPA releases revised MRPs for 543 brands of anti-cancer medicines with the new prices effective from November 9; Jan Swasthya Abhiyan India (JSA India) says controlling trade margins alone is insufficient as life-saving cancer treatment must be affordable based on medical need, not a patient’s ability to pay
NPPA releases revised MRPs for 543 brands of anti-cancer medicines with the new prices effective from November 9; Jan Swasthya Abhiyan India (JSA India) says controlling trade margins alone is insufficient as life-saving cancer treatment must be affordable based on medical need, not a patient’s ability to pay
<iframe src="https://hindustansphere.com/embed/cluster/94ff904aabf9b5f6802e71f675015470bc93f4ee" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="Sharp cuts in price of cancer drugs expose excessive pricing, say health experts"></iframe>
